Estados Unidos · Bolsa y Finanzas · Reuters Business

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

Publicado por Reuters Business · Estados Unidos hace 11 h

Hong Kong-listed Metis TechBio ‌on Monday said it has entered ⁠a collaboration agreement with Eli Lilly worth up to $1.1 billion for ‌the ⁠research and development of…

Leer el artículo completo en Reuters Business Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

También te puede interesar

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

Compartir

También te puede interesar

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC